Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models
Open Access
- 11 November 2022
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (3) , e2201968
Abstract
Graphene‐based 2D nanomaterials possess unique physicochemical characteristics which can be utilized in various biomedical applications, including the transport and presentation of chemotherapeutic agents. In glioblastoma multiforme (GBM), intratumorally administered thin graphene oxide (GO) nanosheets demonstrate a widespread distribution throughout the tumor volume without impact on tumor growth, nor spread into normal brain tissue. Such intratumoral localization and distribution can offer multiple opportunities for treatment and modulation of the GBM microenvironment. Here, the kinetics of GO nanosheet distribution in orthotopic GBM mouse models is described and a novel nano‐chemotherapeutic approach utilizing thin GO sheets as platforms to non‐covalently complex a proteasome inhibitor, bortezomib (BTZ), is rationally designed. Through the characterization of the GO:BTZ complexes, a high loading capacity of the small molecule on the GO surface with sustained BTZ biological activity in vitro is demonstrated. In vivo, a single low‐volume intratumoral administration of GO:BTZ complex shows an enhanced cytotoxic effect compared to free drug in two orthotopic GBM mouse models. This study provides evidence of the potential that thin and small GO sheets hold as flat nanoscale platforms for GBM treatment by increasing the bioavailable drug concentration locally, leading to an enhanced therapeutic effect.Keywords
This publication has 63 references indexed in Scilit:
- Photothermally Triggered Cytosolic Drug Delivery via Endosome Disruption Using a Functionalized Reduced Graphene OxideACS Nano, 2013
- Purified Graphene Oxide Dispersions Lack In Vitro Cytotoxicity and In Vivo PathogenicityAdvanced Healthcare Materials, 2012
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group studyNeuro-Oncology, 2011
- Photothermally Enhanced Photodynamic Therapy Delivered by Nano-Graphene OxideACS Nano, 2011
- Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI‐Grafted Graphene OxideSmall, 2011
- Charge-transfer with graphene and nanotubesMaterials Today, 2010
- Perspectives on Carbon Nanotubes and Graphene Raman SpectroscopyNano Letters, 2010
- Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-CelecoxibCancer Research, 2008
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007
- Increased Permeability of the Blood-Brain Barrier to Chemotherapy in Metastatic Brain Tumors: Establishing a Treatment ParadigmJournal of Clinical Oncology, 2007